Discontinued — last reported Q3 '22

Income taxes receivable

Current Assets

Eli Lilly Income taxes receivable increased by 14.0% to $18.69B in Q3 2025 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2014
Last reportedQ3 2022
Metric ID: income_taxes_receivable

Historical Data

5 periods
 Q4 '22Q3 '23Q4 '24Q2 '25Q3 '25
Value$2.37B$4.08B$7.13B$16.40B$18.69B
QoQ Change—+72.2%+74.8%+130.0%+14.0%
Range$2.37B – $18.69B
CAGR+688.6%
Current Streak4+ quarters growth

Frequently Asked Questions

What is Eli Lilly's income taxes receivable?
Eli Lilly (LLY) reported income taxes receivable of $18.69B in Q3 2025.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.